Migraine drug ups risk for oral birth defects

“The Food and Drug Administration said new data shows expecting mothers taking the drug, sold generically and as Johnson & Johnson’s Topamax, are about 20 times more likely to have their infants develop cleft lips or cleft palate deformities than those who are not treated.

via FDA: migraine drug ups risk for oral birth defects | Reuters.”

Leave a Reply

Your email address will not be published. Required fields are marked *